Immunization with the long-acting monoclonal antibody nirsevimab may provide stronger protection against hospitalizations for ...

Add Yahoo as a preferred source to see more of our stories on Google. Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being ...

Add Yahoo as a preferred source to see more of our stories on Google. RSV is a common virus that infects the nose, throat and lungs, explains Christi Wojewoda, MD, FCAP, Chair of the College of ...

A large Canadian study suggests that nirsevimab, a long-acting monoclonal antibody used to prevent respiratory syncytial ...

(Image source: https://gisaid.org/rsv-subtypes-dashboard) ...

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. RSV season is upon us, which means thousands of children under ...

Flu and Covid, including a new variant called BA.3.2, nicknamed “cicada,” are still circulating, along with several other respiratory illnesses and a nasty stomach bug.

During the first RSV season in which a maternal vaccine and a monoclonal antibody for infants were available, 72% of infants were immunized, this study found. Disparities in access to immunization ...

A study confirms the vaccine gives excellent protection for babies against life-threatening chest infections.

Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms of a severe infection known as RSV or Respiratory Syncytial Virus. The ...

We all know the risks of influenza and COVID for older people. But a third virus, RSV, can also land you in hospital. A free vaccination aims to reduce this risk.

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related RSV ...